Parkinson’s Disease §

Group: 4 #group-4

Relations §

• Genetic Factors: Genetic factors can play a role in the development of Parkinson’s Disease.
• Neurodegeneration: Parkinson’s Disease involves the progressive degeneration of neurons in the brain.
• Negative Symptoms: Negative symptoms can be present in Parkinson’s disease due to dopamine deficiency.
• Non-Motor Symptoms: Parkinson’s Disease can also involve non-motor symptoms.
• Dopamine Deficiency: Parkinson’s Disease is characterized by a deficiency of dopamine, a neurotransmitter in the brain.
• Cognitive Impairment: Parkinson’s disease, a neurodegenerative disorder, can cause cognitive impairment in addition to motor symptoms.
• Protein Folding Diseases: Parkinson’s disease is a protein folding disease caused by the misfolding and aggregation of the alpha-synuclein protein.
• Lewy Bodies: Parkinson’s Disease is characterized by the presence of Lewy bodies, abnormal protein deposits in the brain.
• Deep Brain Stimulation: Deep brain stimulation is a surgical treatment option for advanced Parkinson’s Disease, involving the implantation of electrodes in the brain.
• Environmental Factors: Environmental factors, such as exposure to certain toxins, may contribute to the risk of developing Parkinson’s Disease.
• Medication: Medications are used to manage the symptoms of Parkinson’s Disease.
• Motor Symptoms: Parkinson’s Disease primarily affects motor functions, leading to various motor symptoms.
• Protein Misfolding: Misfolding and aggregation of alpha-synuclein protein are linked to Parkinson’s disease.
• Protein Folding: Misfolding and aggregation of alpha-synuclein are linked to Parkinson’s disease.
• Neurodegenerative Diseases: Parkinson’s disease is a neurodegenerative disease characterized by the aggregation of alpha-synuclein protein into Lewy bodies.
• Dopamine Dysregulation: Parkinson’s disease is characterized by a progressive loss of dopamine-producing neurons, leading to dopamine dysregulation and motor and non-motor symptoms.
• Lewy Bodies: Lewy bodies, composed of aggregated alpha-synuclein protein, are a characteristic feature of Parkinson’s disease.